ResearchMoz

Global Markets Direct Market Research Reports

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

List of reports from Global Markets Direct

Displaying 1 to 30 (of 5983 records)
Emesis (Vomiting) - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Emesis (Vomiting) Pipeline Review, H2 2014, provides an overview of the Emesis (Vomiting)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Emesis (Vomiting), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...
$2000
Myasthenia Gravis - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Myasthenia Gravis Pipeline Review, H2 2014, provides an overview of the Myasthenia Graviss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...
$2000
Malignant Glioma - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Malignant Glioma Pipeline Review, H2 2014, provides an overview of the Malignant Gliomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...
$2000
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Pipeline Review, H2 2014, provides an overview of the Transitional Cell Carcinoma (Urothelial Cell Carcinoma)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma), complete with comparative...
$2000
Retinal Degeneration - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Retinal Degeneration Pipeline Review, H2 2014, provides an overview of the Retinal Degenerations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Retinal Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...
$2000
Restenosis - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Restenosis Pipeline Review, H2 2014, provides an overview of the Restenosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Restenosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule...
$2000
Tauopathies - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Tauopathies Pipeline Review, H2 2014, provides an overview of the Tauopathiess therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tauopathies, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule...
$2000
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Nasopharyngitis (Common Cold) Pipeline Review, H2 2014, provides an overview of the Nasopharyngitis (Common Cold)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nasopharyngitis (Common Cold), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism...
$2000
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Pipeline Review, H2 2014, provides an overview of the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome), complete with comparative...
$2000
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Chemotherapy Induced Peripheral Neuropathy Pipeline Review, H2 2014, provides an overview of the Chemotherapy Induced Peripheral Neuropathys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics...
$2000
Seasonal Allergic Rhinitis - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Seasonal Allergic Rhinitis Pipeline Review, H2 2014, provides an overview of the Seasonal Allergic Rhinitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Seasonal Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...
$2000
Cedar Pollen Allergy - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Cedar Pollen Allergy Pipeline Review, H2 2014, provides an overview of the Cedar Pollen Allergys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cedar Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...
$2000
Sarcoidosis - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Sarcoidosis Pipeline Review, H2 2014, provides an overview of the Sarcoidosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sarcoidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule...
$2000
Plague - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Plague Pipeline Review, H2 2014, provides an overview of the Plagues therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Plague, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along...
$2000
Periodontitis - Pipeline Review, H2 2014
Dec 2014  
Global Markets Directs, Periodontitis Pipeline Review, H2 2014, provides an overview of the Periodontitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Periodontitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and...
$2000
Myotonic Dystrophy - Pipeline Review, H2 2014
Dec 2014  
Myotonic Dystrophy - Pipeline Review, H2 2014 Summary Global Markets Directs, Myotonic Dystrophy - Pipeline Review, H2 2014, provides an overview of the Myotonic Dystrophys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target,...
$2000
Intermittent Claudication - Pipeline Review, H2 2014
Dec 2014  
Intermittent Claudication - Pipeline Review, H2 2014 Summary Global Markets Directs, Intermittent Claudication - Pipeline Review, H2 2014, provides an overview of the Intermittent Claudications therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Intermittent Claudication, complete with comparative analysis at various stages, therapeutics...
$2000
Brain Injury - Pipeline Review, H2 2014
Dec 2014  
Brain Injury - Pipeline Review, H2 2014 Summary Global Markets Directs, Brain Injury - Pipeline Review, H2 2014, provides an overview of the Brain Injurys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...
$2000
Androgenic Alopecia - Pipeline Review, H2 2014
Dec 2014  
Androgenic Alopecia - Pipeline Review, H2 2014 Summary Global Markets Directs, Androgenic Alopecia - Pipeline Review, H2 2014, provides an overview of the Androgenic Alopecias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Androgenic Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target,...
$2000
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014
Dec 2014  
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014 Summary Global Markets Directs, Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014, provides an overview of the Hospital Acquired Pneumonia (HAP)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hospital Acquired Pneumonia (HAP), complete with comparative analysis at...
$2000
Pompe Disease - Pipeline Review, H2 2014
Dec 2014  
Pompe Disease - Pipeline Review, H2 2014 Summary Global Markets Directs, Pompe Disease - Pipeline Review, H2 2014, provides an overview of the Pompe Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pompe Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...
$2000
Rhinovirus Infection - Pipeline Review, H2 2014
Dec 2014  
Rhinovirus Infection - Pipeline Review, H2 2014 Summary Global Markets Directs, Rhinovirus Infection - Pipeline Review, H2 2014, provides an overview of the Rhinovirus Infections therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Rhinovirus Infection, complete with comparative analysis at various stages, therapeutics assessment by drug...
$2000
Chronic Urticaria Or Hives - Pipeline Review, H2 2014
Dec 2014  
Chronic Urticaria Or Hives - Pipeline Review, H2 2014 Summary Global Markets Directs, Chronic Urticaria Or Hives - Pipeline Review, H2 2014, provides an overview of the Chronic Urticaria Or Hivess therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Urticaria Or Hives, complete with comparative analysis at various stages,...
$2000
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014
Dec 2014  
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014 Summary Global Markets Directs, Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014, provides an overview of the Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infectionss therapeutic pipeline. This report provides comprehensive information on the...
$2000
Bone Fracture - Pipeline Review, H2 2014
Dec 2014  
Bone Fracture - Pipeline Review, H2 2014 Summary Global Markets Directs, Bone Fracture - Pipeline Review, H2 2014, provides an overview of the Bone Fractures therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Bone Fracture, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...
$2000
Hyperphosphatemia - Pipeline Review, H2 2014
Dec 2014  
Hyperphosphatemia - Pipeline Review, H2 2014 Summary Global Markets Directs, Hyperphosphatemia - Pipeline Review, H2 2014, provides an overview of the Hyperphosphatemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hyperphosphatemia, complete with comparative analysis at various stages, therapeutics assessment by drug target,...
$2000
Japan Tobacco Inc. - Product Pipeline Review - 2014
Dec 2014  
Global Markets Directs, Japan Tobacco Inc. Product Pipeline Review 2014, provides an overview of the Japan Tobacco Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Japan Tobacco Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target,...
$1500
Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Dec 2014  
Global Markets Directs, Kaken Pharmaceutical Co., Ltd. Product Pipeline Review 2014, provides an overview of the Kaken Pharmaceutical Co., Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kaken Pharmaceutical Co., Ltd.s, complete with comparative analysis at various stages,...
$1500
D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2014
Dec 2014  
Global Markets Directs, D. Western Therapeutics Institute, Inc. Product Pipeline Review 2014, provides an overview of the D. Western Therapeutics Institute, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of D. Western Therapeutics Institute, Inc.s, complete with comparative...
$1500
PharmaEssentia Corporation - Product Pipeline Review - 2014
Dec 2014  
Global Markets Directs, PharmaEssentia Corporation Product Pipeline Review 2014, provides an overview of the PharmaEssentia Corporations pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of PharmaEssentia Corporations, complete with comparative analysis at various stages, therapeutics...
$1500
 
Displaying 1 to 30 (of 5983 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData